• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

国际胸腺恶性肿瘤兴趣小组胸腺瘤复发分类:生存分析及观点。

The International Thymic Malignancy Interest Group Classification of Thymoma Recurrence: Survival Analysis and Perspectives.

机构信息

Thoracic Surgery, Fondazione Policlinico Universitario Agostino Gemelli Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy; Università Cattolica del Sacro Cuore, Rome, Italy.

Thoracic Surgery, Fondazione Policlinico Universitario Agostino Gemelli Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy; Università Cattolica del Sacro Cuore, Rome, Italy.

出版信息

J Thorac Oncol. 2021 Nov;16(11):1936-1945. doi: 10.1016/j.jtho.2021.07.004. Epub 2021 Jul 10.

DOI:10.1016/j.jtho.2021.07.004
PMID:34256111
Abstract

INTRODUCTION

The International Thymic Malignancy Interest Group (ITMIG) classifies thymoma recurrences on the basis of the topographic location, but its effectiveness in prognosis prediction has not been well investigated yet. Aims of this study are to analyze survival outcome of patients surgically treated for thymoma recurrence according to the ITMIG recurrence classification and to investigate possible alternatives.

METHODS

From January 1, 1990, to January 7, 2017, data on 135 surgically treated patients for thymoma recurrence from three high-volume centers were collected and retrospectively analyzed. Patients were classified according to the ITMIG classification as local, regional, and distant. The ITMIG classification and alternative classifications were correlated to overall survival (OS).

RESULTS

According to the ITMIG classification, recurrence was local in 17 (12.5%), regional in 97 (71.8%), and distant in 21 (15.7%) patients, with single localization in 38 (28.2%) and multiple localizations in 97 (71.8%). The 5- and 10-year OS were 79.9% and 49.7% in local, 68.3% and 52.6% in regional, and 66.3% and 35.4% in distant recurrences, respectively, but differences were not statistically significant (p = 0.625). A significant difference in survival was present considering single versus multiple localizations: 5- and 10-year OS of 86.2% and 81.2% versus 61.3% and 31.5% (p = 0.005, hazard ratio = 7.22, 95% confidence interval: 0.147-0.740), respectively. Combining the localization number with the recurrence site, ITMIG locoregional single recurrence had a statistically significant better survival compared with patients with ITMIG locoregional multiple recurrence or ITMIG distant recurrence (p = 0.028). Similarly, a significant difference was present considering intrathoracic single versus intrathoracic multiple versus distant recurrence (p = 0.024).

CONCLUSIONS

The ITMIG classification for thymoma recurrence did not have significant survival differences comparing local, regional, and distant recurrences. Integrating this classification with the number of the localizations may improve its effectiveness in prognosis prediction.

摘要

简介

国际胸腺癌兴趣小组(ITMIG)根据肿瘤的位置对胸腺瘤复发进行分类,但它在预测预后方面的有效性尚未得到很好的研究。本研究的目的是根据 ITMIG 复发分类分析接受手术治疗的胸腺瘤复发患者的生存结果,并探讨可能的替代方案。

方法

从 1990 年 1 月 1 日至 2017 年 1 月 7 日,收集了来自三个高容量中心的 135 例手术治疗的胸腺瘤复发患者的数据,并进行回顾性分析。患者根据 ITMIG 分类分为局部、区域和远处复发。将 ITMIG 分类与其他分类与总生存率(OS)相关联。

结果

根据 ITMIG 分类,17 例(12.5%)患者局部复发,97 例(71.8%)区域复发,21 例(15.7%)远处复发,38 例(28.2%)单发,97 例(71.8%)多发。局部、区域和远处复发的 5 年和 10 年 OS 分别为 79.9%和 49.7%、68.3%和 52.6%、66.3%和 35.4%,但差异无统计学意义(p=0.625)。考虑到单发与多发的定位数量,生存差异具有统计学意义:5 年和 10 年 OS 分别为 86.2%和 81.2%与 61.3%和 31.5%(p=0.005,风险比=7.22,95%置信区间:0.147-0.740)。将定位数量与复发部位相结合,ITMIG 局部区域单发复发与 ITMIG 局部区域多发复发或 ITMIG 远处复发患者的生存情况有统计学显著差异(p=0.028)。同样,胸内单发与胸内多发与远处复发相比,差异具有统计学意义(p=0.024)。

结论

ITMIG 对胸腺瘤复发的分类在局部、区域和远处复发之间没有显著的生存差异。将这种分类与定位数量相结合可能会提高其在预后预测方面的有效性。

相似文献

1
The International Thymic Malignancy Interest Group Classification of Thymoma Recurrence: Survival Analysis and Perspectives.国际胸腺恶性肿瘤兴趣小组胸腺瘤复发分类:生存分析及观点。
J Thorac Oncol. 2021 Nov;16(11):1936-1945. doi: 10.1016/j.jtho.2021.07.004. Epub 2021 Jul 10.
2
Survival Outcome After Surgery in Patients With Thymoma Distant Recurrence.胸腺瘤远处转移患者的手术治疗预后。
J Thorac Oncol. 2024 Jul;19(7):1086-1094. doi: 10.1016/j.jtho.2024.04.004. Epub 2024 Apr 10.
3
Evaluation of the new TNM-staging system for thymic malignancies: impact on indication and survival.胸腺恶性肿瘤新 TNM 分期系统的评估:对适应证和生存的影响。
World J Surg Oncol. 2017 Dec 2;15(1):214. doi: 10.1186/s12957-017-1283-4.
4
Surgical treatment of recurrent thymoma: is it worthwhile?†.复发性胸腺瘤的外科治疗:是否值得?†
Eur J Cardiothorac Surg. 2016 Jan;49(1):327-32. doi: 10.1093/ejcts/ezv086. Epub 2015 Mar 8.
5
Surgical treatment of single and multiple thymoma recurrences.单发性和多发性胸腺瘤复发的外科治疗
Gen Thorac Cardiovasc Surg. 2020 Apr;68(4):350-356. doi: 10.1007/s11748-019-01229-w. Epub 2019 Oct 22.
6
[Comparison of the Masaoka-Koga and The IASLC/ITMIG Proposal for The TNM 
Staging Systems Based on the Chinese Alliance for Research in Thymomas (ChART)
Retrospective Database].基于中国胸腺瘤研究联盟(ChART)回顾性数据库的Masaoka-Koga分期系统与国际肺癌研究协会/国际胸腺恶性肿瘤研究组(IASLC/ITMIG)TNM分期系统提案的比较
Zhongguo Fei Ai Za Zhi. 2016 Jul 20;19(7):425-36. doi: 10.3779/j.issn.1009-3419.2016.07.04.
7
Lymph Node Dissection in Thymic Malignancies: Implication of the ITMIG Lymph Node Map, TNM Stage Classification, and Recommendations.胸腺恶性肿瘤的淋巴结清扫:ITMIG 淋巴结图谱、TNM 分期分类的意义及建议。
J Thorac Oncol. 2016 Jan;11(1):108-14. doi: 10.1016/j.jtho.2015.09.001.
8
Prognostic factors after treatment for iterative thymoma recurrences: A multicentric experience.治疗复发性胸腺瘤后预后因素:一项多中心经验。
Lung Cancer. 2019 Dec;138:27-34. doi: 10.1016/j.lungcan.2019.09.024. Epub 2019 Sep 30.
9
Assessment of the ITMIG Statement on the WHO Histological Classification and of the Eighth TNM Staging of Thymic Epithelial Tumors of a Series of 188 Thymic Epithelial Tumors.评估 ITMIG 关于世卫组织组织学分类的声明以及 188 例胸腺癌系列中第八版胸腺上皮肿瘤 TNM 分期。
J Thorac Oncol. 2017 Oct;12(10):1571-1581. doi: 10.1016/j.jtho.2017.06.072. Epub 2017 Jul 8.
10
Reproducibility of 3 histologic classifications and 3 staging systems for thymic epithelial neoplasms and its effect on prognosis.胸腺上皮性肿瘤3种组织学分类和3种分期系统的可重复性及其对预后的影响。
Am J Surg Pathol. 2015 Apr;39(4):427-41. doi: 10.1097/PAS.0000000000000391.

引用本文的文献

1
Narrative review of the prognostic significance of primary tumor size in thymic epithelial tumor.胸腺上皮肿瘤中原发肿瘤大小的预后意义的叙述性综述。
Mediastinum. 2025 Jun 25;9:14. doi: 10.21037/med-25-3. eCollection 2025.
2
Managing recurrent thymic epithelial tumors after resection: outcomes and role of re-resection.胸腺上皮肿瘤切除术后复发病例的管理:再次切除的疗效及作用
Mediastinum. 2024 Nov 20;8:49. doi: 10.21037/med-24-26. eCollection 2024.
3
Stereotactic Ablative Radiation Therapy for Sacral Bone Metastasis in Recurrent Type A Thymoma: A Two-Year Follow-Up Demonstrating Pain Reduction and Local Control.
立体定向消融放疗治疗复发性 A 型胸腺瘤骶骨转移:两年随访显示疼痛减轻和局部控制
Cureus. 2024 Aug 18;16(8):e67142. doi: 10.7759/cureus.67142. eCollection 2024 Aug.
4
Comparative Analysis of Comprehensive Genomic Profile in Thymomas and Recurrent Thymomas Reveals Potentially Actionable Mutations for Target Therapies.胸腺瘤与复发性胸腺瘤的综合基因组分析比较揭示了潜在的靶向治疗药物作用靶点突变。
Int J Mol Sci. 2024 Sep 3;25(17):9560. doi: 10.3390/ijms25179560.
5
Updated outcomes of surgical treatment for recurrent thymic tumour: a report from the Japanese nationwide database.复发性胸腺瘤外科治疗的最新结果:来自日本全国数据库的报告
Interdiscip Cardiovasc Thorac Surg. 2024 Jun 5;38(6). doi: 10.1093/icvts/ivae064.
6
ITMIG 2021 Tumor Board: a case of a 37-year-old man with TNM stage IVA thymoma.国际胸腺恶性肿瘤兴趣小组(ITMIG)2021年肿瘤病例讨论会:一名37岁IV A期胸腺瘤男性患者的病例
Mediastinum. 2022 Sep 25;6:26. doi: 10.21037/med-22-3. eCollection 2022.
7
Histological Classification and Invasion Prediction of Thymoma by Machine Learning-Based Computed Tomography Imaging.基于机器学习的 CT 影像学对胸腺瘤的组织学分型与侵袭预测
Contrast Media Mol Imaging. 2022 Aug 5;2022:4594757. doi: 10.1155/2022/4594757. eCollection 2022.